Zeria Pharmaceutical Co Ltd
TSE:4559

Watchlist Manager
Zeria Pharmaceutical Co Ltd Logo
Zeria Pharmaceutical Co Ltd
TSE:4559
Watchlist
Price: 2 240 JPY 0.86% Market Closed
Market Cap: 98.7B JPY
Have any thoughts about
Zeria Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Zeria Pharmaceutical Co Ltd stock under the Base Case scenario is 4 716.55 JPY. Compared to the current market price of 2 240 JPY, Zeria Pharmaceutical Co Ltd is Undervalued by 53%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
4 716.55 JPY
Undervaluation 53%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Zeria Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Zeria Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Zeria Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Zeria Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Zeria Pharmaceutical Co Ltd.

What unique competitive advantages
does Zeria Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Zeria Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Zeria Pharmaceutical Co Ltd.

Provide P/S
for Zeria Pharmaceutical Co Ltd.

Provide P/E
for Zeria Pharmaceutical Co Ltd.

Provide P/OCF
for Zeria Pharmaceutical Co Ltd.

Provide P/FCFE
for Zeria Pharmaceutical Co Ltd.

Provide P/B
for Zeria Pharmaceutical Co Ltd.

Provide EV/S
for Zeria Pharmaceutical Co Ltd.

Provide EV/GP
for Zeria Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Zeria Pharmaceutical Co Ltd.

Provide EV/EBIT
for Zeria Pharmaceutical Co Ltd.

Provide EV/OCF
for Zeria Pharmaceutical Co Ltd.

Provide EV/FCFF
for Zeria Pharmaceutical Co Ltd.

Provide EV/IC
for Zeria Pharmaceutical Co Ltd.

Show me price targets
for Zeria Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Zeria Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Zeria Pharmaceutical Co Ltd?

What are the Net Income projections
for Zeria Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Zeria Pharmaceutical Co Ltd?

What are the EPS projections
for Zeria Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Zeria Pharmaceutical Co Ltd?

What are the EBIT projections
for Zeria Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Zeria Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Zeria Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Zeria Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Zeria Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Zeria Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Zeria Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Zeria Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Zeria Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Zeria Pharmaceutical Co Ltd.

Provide ROE
for Zeria Pharmaceutical Co Ltd.

Provide ROA
for Zeria Pharmaceutical Co Ltd.

Provide ROIC
for Zeria Pharmaceutical Co Ltd.

Provide ROCE
for Zeria Pharmaceutical Co Ltd.

Provide Gross Margin
for Zeria Pharmaceutical Co Ltd.

Provide Operating Margin
for Zeria Pharmaceutical Co Ltd.

Provide Net Margin
for Zeria Pharmaceutical Co Ltd.

Provide FCF Margin
for Zeria Pharmaceutical Co Ltd.

Show all solvency ratios
for Zeria Pharmaceutical Co Ltd.

Provide D/E Ratio
for Zeria Pharmaceutical Co Ltd.

Provide D/A Ratio
for Zeria Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Zeria Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Zeria Pharmaceutical Co Ltd.

Provide Quick Ratio
for Zeria Pharmaceutical Co Ltd.

Provide Current Ratio
for Zeria Pharmaceutical Co Ltd.

Provide Cash Ratio
for Zeria Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Zeria Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Zeria Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Zeria Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Zeria Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zeria Pharmaceutical Co Ltd

Current Assets 60.5B
Cash & Short-Term Investments 19.9B
Receivables 23.6B
Other Current Assets 17B
Non-Current Assets 91.6B
Long-Term Investments 9.3B
PP&E 26.6B
Intangibles 41.8B
Other Non-Current Assets 13.9B
Current Liabilities 54.6B
Accounts Payable 3.4B
Accrued Liabilities 1.4B
Other Current Liabilities 49.7B
Non-Current Liabilities 15.6B
Long-Term Debt 7.1B
Other Non-Current Liabilities 8.5B
Efficiency

Earnings Waterfall
Zeria Pharmaceutical Co Ltd

Revenue
78.9B JPY
Cost of Revenue
-21.1B JPY
Gross Profit
57.7B JPY
Operating Expenses
-47.6B JPY
Operating Income
10.1B JPY
Other Expenses
-1.1B JPY
Net Income
9B JPY

Free Cash Flow Analysis
Zeria Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Zeria Pharmaceutical Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
56/100
Profitability
Score

Zeria Pharmaceutical Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Zeria Pharmaceutical Co Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Negative Net Debt
Long-Term Solvency
73/100
Solvency
Score

Zeria Pharmaceutical Co Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Zeria Pharmaceutical Co Ltd

Wall Street analysts forecast Zeria Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zeria Pharmaceutical Co Ltd is 3 233.4 JPY with a low forecast of 3 201.7 JPY and a high forecast of 3 328.5 JPY.

Lowest
Price Target
3 201.7 JPY
43% Upside
Average
Price Target
3 233.4 JPY
44% Upside
Highest
Price Target
3 328.5 JPY
49% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Zeria Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Zeria Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Zeria Pharmaceutical Co Ltd Logo
Zeria Pharmaceutical Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

98.7B JPY

Dividend Yield

2.01%

Description

Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 1,690 full-time employees. The firm operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.

Contact

TOKYO-TO
Chuo-Ku
10-11, Nihombashi Kobuna-cho
+81336632351.0
www.zeria.co.jp

IPO

1998-12-22

Employees

1 690

Officers

Chairman & CEO
Mr. Sachiaki Ibe
President, COO & Representative Director
Mr. Mitsuhiro Ibe

See Also

Discover More
What is the Intrinsic Value of one Zeria Pharmaceutical Co Ltd stock?

The intrinsic value of one Zeria Pharmaceutical Co Ltd stock under the Base Case scenario is 4 716.55 JPY.

Is Zeria Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 2 240 JPY, Zeria Pharmaceutical Co Ltd is Undervalued by 53%.

Back to Top